<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13736">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00371787</url>
  </required_header>
  <id_info>
    <org_study_id>P/240/06/CV</org_study_id>
    <nct_id>NCT00371787</nct_id>
  </id_info>
  <brief_title>Evaluation of the Performance of Non-molded Soft Contact Lenses</brief_title>
  <official_title>Evaluation of the Performance of Non-molded Soft Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Waterloo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CIBA VISION</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Waterloo</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the performance of the study soft lens for vision, comfort, physiology and lens
      surface properties.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the performance of the study soft lens for vision, comfort, physiology and lens
      surface properties in a group of participants who present with lens related changes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>level of vision measured using high contrast acuity chart, higher (more positive)logMAR indicates worse vision.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>9 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>level of vision measured using high contrast acuity chart, higher (more positive)logMAR indicates worse vision.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neovascularisation</measure>
    <time_frame>baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>length of the blood vessels entering the superior cornea, higher number means longer blood vessel penetration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neovascularization</measure>
    <time_frame>9 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>length of the blood vessels entering the superior cornea, higher number means longer blood vessel penetration.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Ametropia</condition>
  <arm_group>
    <arm_group_label>soft contact lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>non-lens wear</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Soft contact lens</intervention_name>
    <description>Soft contact lens</description>
    <arm_group_label>soft contact lens</arm_group_label>
    <other_name>Custom O2Optix</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, good health, age &gt;17yrs, able to wear contact lenses as primary
             vision correction, able to see well and achieve good fit with study lens, has
             understood &amp; signed consent form.

        Exclusion Criteria:

          -  Has active ocular disease, uses topical eye medication, wears gas permeable/silicone
             hydrogel /overnight wear contact lenses, is a participant in another clinical study,
             is deemed unsuitable for soft contact lens wear.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Desmond Fonn</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Contact Lens Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Contact Lens Research, University of Waterloo,</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <lastchanged_date>January 5, 2011</lastchanged_date>
  <firstreceived_date>September 1, 2006</firstreceived_date>
  <firstreceived_results_date>November 8, 2010</firstreceived_results_date>
  <responsible_party>
    <name_title>Craig Woods, Research Manager</name_title>
    <organization>CCLR</organization>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants recruited from local communities in Kitchener-Waterloo, Canada between July 2006 and Feb 2007</recruitment_details>
      <pre_assignment_details>38 participants recruited and screened; 4 withdrew by subject</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Treatment Group</title>
          <description>soft lens wearers with sign of hypoxia and high prescription</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>normal non-lens wearers</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment Group</title>
          <description>soft lens wearers with sign of hypoxia and high prescription</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>normal non-lens wearers</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="26"/>
                <measurement group_id="B2" value="12"/>
                <measurement group_id="B3" value="38"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="26"/>
                <measurement group_id="B2" value="12"/>
                <measurement group_id="B3" value="38"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="31.6" spread="10.75"/>
                <measurement group_id="B2" value="33.25" spread="6.9"/>
                <measurement group_id="B3" value="32.4" spread="9.9"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="18"/>
                <measurement group_id="B2" value="8"/>
                <measurement group_id="B3" value="26"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="8"/>
                <measurement group_id="B2" value="4"/>
                <measurement group_id="B3" value="12"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Canada</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="26"/>
                <measurement group_id="B2" value="12"/>
                <measurement group_id="B3" value="38"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>level of vision measured using high contrast acuity chart, higher (more positive)logMAR indicates worse vision.</description>
        <time_frame>baseline</time_frame>
        <safety_issue>No</safety_issue>
        <population>Per Protocol. Only the data from participants who completed all study visits were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>soft lens wearers with sign of hypoxia and high prescription</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>normal non-lens wearers</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="26"/>
                  <measurement group_id="O2" value="12"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Visual Acuity</title>
            <description>level of vision measured using high contrast acuity chart, higher (more positive)logMAR indicates worse vision.</description>
            <units>logMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.01" spread="0.09"/>
                  <measurement group_id="O2" value="-0.07" spread="0.11"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>level of vision measured using high contrast acuity chart, higher (more positive)logMAR indicates worse vision.</description>
        <time_frame>9 month</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>soft lens wearers with sign of hypoxia and high prescription</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>normal non-lens wearers</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="26"/>
                  <measurement group_id="O2" value="12"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Visual Acuity</title>
            <description>level of vision measured using high contrast acuity chart, higher (more positive)logMAR indicates worse vision.</description>
            <units>logMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.01" spread="0.09"/>
                  <measurement group_id="O2" value="-0.08" spread="0.10"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Neovascularisation</title>
        <description>length of the blood vessels entering the superior cornea, higher number means longer blood vessel penetration.</description>
        <time_frame>baseline</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>soft lens wearers with sign of hypoxia and high prescription</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>normal non-lens wearers</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="26"/>
                  <measurement group_id="O2" value="12"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Neovascularisation</title>
            <description>length of the blood vessels entering the superior cornea, higher number means longer blood vessel penetration.</description>
            <units>mm</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.84" spread="0.39"/>
                  <measurement group_id="O2" value="0.35" spread="0.16"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Neovascularization</title>
        <description>length of the blood vessels entering the superior cornea, higher number means longer blood vessel penetration.</description>
        <time_frame>9 month</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>soft lens wearers with sign of hypoxia and high prescription</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>normal non-lens wearers</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="26"/>
                  <measurement group_id="O2" value="12"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Neovascularization</title>
            <description>length of the blood vessels entering the superior cornea, higher number means longer blood vessel penetration.</description>
            <units>mm</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.63" spread="0.2"/>
                  <measurement group_id="O2" value="0.35" spread="0.19"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Treatment Group</title>
          <description>soft lens wearers with sign of hypoxia and high prescription</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>normal non-lens wearers</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Craig Woods</name_or_title>
      <organization>Centre for Contact Lens Research</organization>
      <phone>1-519-888-4567 ext 36547</phone>
      <email>cawoods@uwaterloo.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
